Quantcast
Last updated on April 24, 2014 at 0:08 EDT

Latest National Institute on Drug Abuse Stories

95b2eb279c96c26c5946765399727f031
2010-12-14 12:50:00

According to an annual government study of high-schoolers across the country, teenagers are using more marijuana and less alcohol. The Monitoring the Future survey released by the National Institutes of Health said that about 6.1 percent of high-school seniors reported using marijuana this year, up from 5.2 percent in 2009. Marijuana use by 10th-graders jumped up 2.8 percent to 3.3 percent, and for 8th-grade students it edged up from 1.0 percent to 1.2 percent. "These high rates of...

2010-12-14 00:01:32

November 2010 marked the first National Drug Fact Week. Recovery Now TV commends this effort in helping to fight teen drug addiction and promoting teen drug treatment. Los Angeles, CA (PRWEB) December 13, 2010 Recovery Now TV noted the significance of the first annual National Drug Fact Week, which occurred November 8th-14th 2010. The National Institute on Drug Abuse sponsored this event and partners included Discovery, MTV and Community Anti-Drug Coalition of America. The primary goal of...

2010-11-04 10:08:00

DETROIT, Nov. 4, 2010 /PRNewswire-USNewswire/ -- A recent study by researchers at Wayne State University showed that both teens and parents substantially underreported drug use, even when they had knowledge that a certificate of confidentiality protected them as a participant in the research study. According to Virginia Delaney-Black, M.D., M.P.H., professor of pediatrics at Wayne State University's School of Medicine and Children's Hospital of Michigan and lead author of the study,...

2010-10-14 06:00:00

SEATTLE, Oct. 14 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER) today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute...

2010-09-22 06:00:00

SOUTH SAN FRANCISCO, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) today announced that patient enrollment is now complete in the confirmatory, Phase 3 clinical study of Probuphine for the treatment of opioid addiction. This placebo and active controlled Phase 3 study is being conducted at 20 sites in the United States and the results are expected in the second quarter of 2011, about three months ahead of the original schedule. This...

2010-09-22 06:00:00

ST. JOSEPH, Mich., Sept. 22 /PRNewswire/ -- GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal. The SBIR grant will be used to develop a database and systems biology tool-set specifically designed for the study of the...

2010-09-20 22:35:07

Drug created by UCI, Italian team inhibits enzyme that breaks down anandamide American and Italian researchers have found that a novel drug allows anandamide "“ a marijuana-like chemical in the body "“ to effectively control pain at the site of an injury. Led by Daniele Piomelli, the Louise Turner Arnold Chair in Neurosciences and director of the Center for Drug Discovery at UC Irvine, the study suggests that such compounds could form the basis of pain medications that don't...

2010-09-14 01:08:09

Selected awardee studies the mechanisms of latent HIV infection to develop counter measures aimed at eliminating the virus The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today that Dr. Eric M. Verdin of the J. David Gladstone Institutes in San Francisco, Calif., has been selected as the 2010 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research for his proposal to study the mechanisms of latent HIV infection. NIDA's annual Avant-Garde...

2010-08-16 14:25:09

Findings represent additional clues to help predict vulnerability to drug abuse A regulatory protein best known for its role in a rare genetic brain disorder also may play a critical role in cocaine addiction, according to a recent study in rats, funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the journal Nature Neuroscience. Researchers at the Scripps Research Institute in Jupiter, Fla. found that...

2010-08-03 06:00:00

SOUTH SAN FRANCISCO, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule. This placebo and active controlled Phase 3 study is being conducted at 21 sites...